| Event chart ROCHE HOLDING AG |
|
|
|
| Upcoming events on ROCHE HOLDING AG |
|
| 07/21/22 | 01:00am | | Interim 2022 Earnings Release |
| 07/21/22 | 08:00am | | Interim 2022 Earnings Call |
| 07/26/22 | 07:00pm | | American Association for Clinical Chemistry Scientific Meeting - Clinical Lab Exposition |
| 08/02/22 | | Alzheimer's Association International Conference |
| 09/07/22 | 10:00pm | | Goldman Sachs European Medtech and Healthcare Services Conference |
| 09/15/22 | 10:00pm | | CITIC CLSA Investors´ Forum |
| 09/27/22 | 04:00am | | BNP Paribas Exane ESG Conference |
| 10/18/22 | | Q3 2022 Sales and Revenue Release |
| 11/08/22 | 12:00pm | | Credit Suisse US Healthcare Conference |
| 02/02/23 | | FY 2022 Earnings Release (Projected) |
|
| Past events on ROCHE HOLDING AG |
|
| 06/23/22 | 05:00am | | JP Morgan European Healthcare Conference |
| 06/21/22 | 01:00pm | | BofA Napa Biopharma Conference |
| 06/16/22 | 05:00am | | Citi European Healthcare Conference |
| 06/15/22 | 01:00pm | | Goldman Sachs Global Healthcare Conference |
| 06/09/22 | 10:00am | | Barclays European Select Conference |
| 06/08/22 | 10:00am | | Jefferies Healthcare Conference |
| 06/06/22 | 10:00am | | American Society of Clinical Oncology Meeting |
| 06/03/22 | | American Society of Clinical Oncology Meeting - Abstract# TPS9141 |
| 06/03/22 | | American Society of Clinical Oncology Meeting - Abstract# 589 |
| 06/03/22 | | American Society of Clinical Oncology Meeting - Abstract# 3130 |
|
| Past dividends on ROCHE HOLDING AG |
|
| 03/17/22 | | Annual 9.3 CHF |
| 03/18/21 | | Annual 9.1 CHF |
| 03/19/20 | | Annual 9 CHF |
| 03/07/19 | | Annual 8.7 CHF |
| 03/15/18 | | Annual 8.3 CHF |
| 03/16/17 | | Annual 8.2 CHF |
| 03/03/16 | | Annual 8.1 CHF |
| 03/05/15 | | 8 chf |
| 03/06/14 | | Annual 7.8 CHF |
| 03/07/13 | | Annual 7.35 CHF |
|
|
|
| Fiscal Period : December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
Sales
M CHF |
Released
Forecast
Spread | 53 299
53 126
0,33% | 56 846
56 448
0,70% | 61 466
61 789
-0,52% | 58 323
59 276
-1,6% | 62 801
62 243
0,90% |
63 522
|
Operating income
(EBITDA)
M CHF |
Released
Forecast
Spread | 21 201
20 725
2,3% | 22 825
22 398
1,9% | 25 419
24 199
5,0% | 24 281
24 532
-1,0% | 24 692
25 569
-3,4% |
25 586
|
Operating profit
(EBIT)
M CHF |
Released
Forecast
Spread | 19 012
19 361
-1,8% | 20 505
20 431
0,36% | 22 479
22 680
-0,89% | 21 536
21 622
-0,40% | 21 897
22 784
-3,9% |
22 299
|
Pre-Tax Profit
(EBT)
M CHF |
Released
Forecast
Spread | 12 248
14 738
-17% | 14 148
17 012
-17% | 16 614
18 369
-9,6% | 17 965
18 289
-1,8% | 17 398
20 328
-14% |
19 749
|
Net income
M CHF |
Released
Forecast
Spread | 8 633
10 674
-19% | 10 500
12 780
-18% | 13 497
14 257
-5,3% | 14 295
14 335
-0,28% | 13 930
15 065
-7,5% |
14 954
|
EPS
CHF |
Released
Forecast
Spread | 10,0
12,5
-20% | 12,2
15,3
-20% | 15,6
16,6
-5,7% | 16,5
16,5
-0,02% | 16,2
17,8
-9,2% |
18,7
| | Announcement Date | 02/01/2018 | 01/31/2019 | 01/30/2020 | 02/04/2021 | 02/03/2022 | - |
|
|
|
| Fiscal Period : December | 2017 S2 | 2018 S1 | 2018 S2 | 2019 S1 | 2019 Q4 | 2019 S2 | 2020 Q1 | 2020 Q2 | 2020 S1 | 2020 Q3 | 2020 Q4 | 2020 S2 | 2021 Q1 | 2021 Q2 | 2021 S1 | 2021 Q3 | 2021 Q4 | 2021 S2 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2022 S1 | 2022 S2 | 2023 Q1 | 2023 S1 | 2023 S2 |
Sales
M CHF |
Released
Forecast
Spread | 26 955
26 762
0,72% | 28 111
27 568
2,0% | 28 735
28 366
1,3% | 30 469
30 275
0,64% | 15 400
15 852
-2,8% | 30 997
31 426
-1,4% | 15 143
14 736
2,8% | 14 138
14 989
-5,7% | 29 281
30 369
-3,6% | 14 698
15 091
-2,6% | 14 344
15 207
-5,7% | 29 042
30 037
-3,3% | 14 930
14 963
-0,22% | 15 783
15 174
4,0% | 30 713
30 038
2,2% | 15 971
15 787
1,2% | 16 117
15 745
2,4% | 32 088
31 791
0,93% | 16 445
16 072
2,3% |
15 581
|
15 573
|
16 087
|
31 981
|
31 831
|
16 045
|
31 915
|
32 250
|
Operating profit
(EBIT)
M CHF |
Released
Forecast
Spread | 8 877
9 153
-3,0% | 11 162
10 480
6,5% | 9 343
9 269
0,80% | 12 363
11 862
4,2% |
| 10 116
10 525
-3,9% |
|
| 11 766
11 824
-0,49% |
|
| 9 770
9 915
-1,5% |
|
| 11 652
11 715
-0,53% |
|
| 10 245
11 539
-11% |
|
|
|
|
12 296
|
10 524
|
|
|
|
Pre-Tax Profit
(EBT)
M CHF |
Released
Forecast
Spread |
|
| 4 654
8 143
-43% | 10 354
11 145
-7,1% |
| 6 260
9 758
-36% |
|
| 10 181
10 632
-4,2% |
|
| 7 784
9 124
-15% |
|
| 9 887
10 773
-8,2% |
|
| 7 511
10 155
-26% |
|
|
|
|
11 259
|
9 812
|
|
|
|
Net income
M CHF |
Released
Forecast
Spread |
|
| 3 191
6 551
-51% | 8 619
8 910
-3,3% |
| 4 878
6 896
-29% |
|
| 8 079
8 713
-7,3% |
|
| 6 216
7 084
-12% |
|
| 7 803
8 526
-8,5% |
|
| 6 127
7 703
-20% |
|
|
|
|
8 390
|
7 526
|
|
|
|
EPS
|
Released
Forecast
Spread | 3,67
6,38
-42% | 8,51
8,26
3,0% | 3,70
7,29
-49% | 9,99
9,66
3,4% |
| 5,63
7,56
-26% |
|
| 9,32
9,70
-3,9% |
|
| 7,20
8,06
-11% |
|
| 9,05
9,29
-2,6% |
|
| 7,15
9,30
-23% |
|
|
|
|
10,4
|
9,29
|
|
|
| | Announcement Date | 02/01/2018 | 07/26/2018 | 01/31/2019 | 07/25/2019 | 01/30/2020 | 01/30/2020 | 04/22/2020 | 07/23/2020 | 07/23/2020 | 10/15/2020 | 02/04/2021 | 02/04/2021 | 04/21/2021 | 07/22/2021 | 07/22/2021 | 10/20/2021 | 02/03/2022 | 02/03/2022 | 04/25/2022 | - | - | - | - | - | - | - | - | |
|
|
| Upcoming sector events for ROCHE HOLDING AG |
|
| |
|
| Past sector events for ROCHE HOLDING AG |
|
| |
|
|
|
|
Pharmaceutical companies still have the upper hand |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
Previous year
